| P50 | author | Thomas Fovet | Q56526838 |
| P2093 | author name string | P Thomas | |
| | A Amad | |
| P2860 | cites work | Psychosocial interventions for people with both severe mental illness and substance misuse | Q24197576 |
| | Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology | Q24602238 |
| | Revisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior | Q26801102 |
| | Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review | Q28238516 |
| | Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 |
| | Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis | Q33885557 |
| | Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort | Q34440708 |
| | Substance misuse in patients with schizophrenia: epidemiology and management | Q34585142 |
| | Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia | Q37063606 |
| | Development of social functioning in preschizophrenia children and adolescents: a systematic review | Q37208826 |
| | Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver | Q37665156 |
| | Why do patients with psychosis use cannabis and are they ready to change their use? | Q37822518 |
| | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings | Q38124448 |
| | Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. | Q38133045 |
| | The social and economic burden of treatment-resistant schizophrenia: a systematic literature review | Q38133371 |
| | Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades--a Danish nationwide study from 1980 to 2010. | Q38427112 |
| | Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study | Q40078822 |
| | Reasons for cannabis use in psychosis | Q48444646 |
| | Course and predictors of suicidality over the first two years of treatment in first-episode schizophrenia spectrum psychosis. | Q51851545 |
| | Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. | Q52016145 |
| | Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. | Q55056971 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | S18-S22 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | L'Encephale: revue de psychiatrie clinique biologique et therapeutique | Q3202945 |
| P1476 | title | [Schizophrenia and addictions: dangerous links] | |
| P478 | volume | 42 Suppl 3 | |